Sep 29, 2021 / 05:00PM GMT
Destiny Alexandra Hance Buch - Ladenburg Thalmann & Co. Inc., Research Division - Analyst
Hello, and welcome to Ladenburg Thalmann R&D Showcase. Our showcase is designed to highlight company products in the clinical or regulatory process. Today, we are excited to highlight Jaguar Health, and we'll turn it over to management in a moment.
We would first like to bring your attention to our necessary disclosures. Further, we would like to reiterate this webinar is being recorded, and intended for the investment community. We'd also like to note the risks associated with owning shares of Jaguar Health. If you have any questions or concerns, please contact me, Destiny Hance at [email protected].
Without further ado, I will turn it over to Jeffrey Cohen, Managing Director, Equity Research. Jeff?
Jeffrey Scott Cohen - Ladenburg Thalmann & Co. Inc., Research Division - MD of Equity Research
Thank you, Destiny, and thank you, everyone for joining us. Today, we're going to be speaking with both Lisa Conte, CEO of Jaguar Health; as well as
Jaguar Health Inc at Ladenburg Thalmann R&D Webinar Transcript
Sep 29, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers